PRI’s Policy Alert
View this email in your browser ([link removed])
Dispelling Some Of The COVID-19 Unknowns
Issues & Insights | Henry Miller, M.S., M.D.
April 2, 2020
On the medical front, let’s consider what we do know. First and foremost, the situation in the U.S. continues to worsen. The nation’s death toll is rising exponentially, and the steepness of New York’s curve is terrifying. So are the number of confirmed infections, but that statistic is of limited value, inasmuch as its accuracy depends on the (now finally increasing) numbers of tests conducted.
Read more. . . ([link removed])
[link removed]
[link removed]
[link removed]
Listen to PRI's "Next Round" Podcast
Mark Skousen – On These Uncertain Times
March 30, 2020
Dr. Mark Skousen is one of the most prominent libertarians in the country and founder of FreedomFest – the largest gathering of libertarians in the world. Dr. Skousen also teaches economics at Chapman University. In this podcast, we discuss the economic impact of the coronavirus, the financial markets, politics, California, and teaching economics to a new generation.
Click here to listen . . . ([link removed])
------------------------------------------------------------
In coronavirus battle, price controls would make it harder to develop lifesaving drugs
Fox News | Sally C. Pipes
March 30, 2020
Investors only fund these risky projects if they foresee a reasonable chance of recouping their money. That’s why so much drug research occurs in the United States, which has fewer rules governing drug prices than other developed nations. U.S. companies develop half of all new medicines; European firms are responsible for just a third.
Read more. . . ([link removed])
------------------------------------------------------------
Dr. Henry Miller Answers Viewer Questions as Featured Expert on Fox News Live Blog
Fox News | Henry Miller, M.S., M.D.
April 1, 2020
Dr. Henry Miller on Foxnews.com’s “Coronavirus Live Blog.” The live blog is a daily online blog where written questions are submitted to a public health expert. Dr. Miller answered written questions on Wednesday morning about a potential vaccine, social distancing, transmission of COVID-19, and more.
R ([link removed]) ead more. . . ([link removed])
------------------------------------------------------------
Coronavirus school shutdowns foster online learning alternatives
Washington Examiner | Lance Izumi
April 1, 2020
In order to ensure that it promotes rather than hinders this needed flexibility to educate, the Department of Education recently issued clarifying information on the use of distance learning for students saying, “No one wants to have learning coming to a halt across America due to the COVID-19 outbreak, and the U.S. Department of Education does not want to stand in the way of good faith efforts to educate students on-line.”
Read more. . . ([link removed])
------------------------------------------------------------
Expand Pharmacists’ Authority To Promote Access To Forthcoming COVID-19 Vaccine
Forbes | Wayne Winegarden
March 31, 2020
Thanks to the funding provided by the NIH, a Phase 1 clinical trial for a COVID-19 vaccine is underway. In separate efforts, Inovio, Sanofi, Vaxart, GlaxoSmithKline, and Johnson & Johnson are all developing potential vaccines. In total, “about 35 companies and academic institutions are racing to create a vaccine, at least four of which already have candidates they have been testing in animals. The first of these – produced by Boston-based biotech firm Moderna – will enter human trials imminently.”
Read more. . . ([link removed])
------------------------------------------------------------
============================================================
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
Copyright © 2020 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.
Our mailing address is:
101 Montgomery Street, Suite 1300, San Francisco, CA 94104
** ([link removed])
Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.
